Swedish Orphan Biovitrum AB (publ) (Sobitm) (STO:SOBI) is pleased to announce that Canada's Drug Agency (CDA) has issued a positive reimbursement recommendation with conditions for PrEMPAVELI® ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results